Antisense Therapeutics wins approval for stem cell cancer treatment trial in … – Proactive Investors Australia
|
Antisense Therapeutics wins approval for stem cell cancer treatment trial in …
Proactive Investors Australia … has won approval for a stem cell cancer treatment trial in Melbourne. Antisense Therapeutics (ASX:ANP) should trade firmer after receiving approval to conduct a Phase 1 Stem Cell Mobilisation Human Proof of Concept trial for its anticancer drug … |
